• Metformin HCl Suppresses Achilles Tendon Ossification via Nr

  2026-05-15

  This study establishes that Metformin Hydrochloride (Metformin HCl) inhibits heterotopic ossification in mouse Achilles tendon by targeting the Nr4a1/Wnt/β-catenin signaling axis. These findings provide a mechanistic basis for using metabolic pathway modulators to address pathological bone formation in soft tissues.

• Cyclic Pifithrin-α Hydrobromide: Precision p53 Inhibitor Wor

  2026-05-15

  Cyclic Pifithrin-α hydrobromide delivers controllable, selective inhibition of p53, enabling researchers to dissect apoptosis and DNA damage responses in both cancer and neuroinflammatory models. This guide translates the latest protocol strategies, troubleshooting insights, and reference-driven innovations into streamlined, reproducible workflows.

• 2-Hydroxypropyl-β-cyclodextrin: Practical Use and QC Guide

  2026-05-14

  2-Hydroxypropyl-β-cyclodextrin addresses the solubility limitations of hydrophobic, poorly water-soluble research compounds, particularly those with aromatic or phenyl groups, by forming inclusion complexes that enhance their aqueous solubility. Its application is best confined to pharmaceutical and biochemical workflows as a drug formulation excipient or solubility enhancer; broader uses are not supported by current product documentation.

• Primidone (B2120): Reliable TRPM3 & RIPK1 Inhibition in Rese

  2026-05-14

  This article addresses common laboratory challenges in cell viability and neurodegenerative disease modeling, demonstrating how Primidone (SKU B2120) delivers reproducible and literature-backed results. By exploring real-world scenarios, we highlight protocol optimization, assay compatibility, and vendor reliability, equipping researchers with actionable insights for robust experimentation.

• Angiotensin I: Pivotal Mechanisms and Translational Leverage

  2026-05-13

  This thought-leadership article synthesizes mechanistic insight and actionable strategy for translational researchers employing Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) in cardiovascular and neuroendocrine research. Anchored in evidence and protocol guidance, it positions APExBIO’s Angiotensin I as an indispensable tool for decoding the renin-angiotensin system, benchmarking against advanced analytics, and elevating experimental rigor. The article bridges mechanistic biochemistry with translational imperatives, integrating recent findings on spectral interference and bioaerosol detection to inform best practices and future directions.

• Super-Enhancer Hijacking of LINC01977 Drives LUAD via TGF-β/

  2026-05-13

  Zhang et al. (2022) identify how super-enhancer hijacking of the lncRNA LINC01977 promotes malignancy in early-stage lung adenocarcinoma (LUAD) by activating the canonical TGF-β/SMAD3 pathway. Their integrative approach highlights novel epigenetic mechanisms and potential targets for therapeutic intervention in cancer biology research.

• Procainamide Hydrochloride: From Electrophysiology to Epigen

  2026-05-12

  This in-depth thought-leadership article explores the evolving role of Procainamide Hydrochloride as both a cardiac sodium channel blocker and an epigenetic modulator, offering translational researchers mechanistic insights, evidence-led protocol recommendations, and strategic guidance for leveraging its dual-action profile. Building on recent advances in tumor immunology and workflow integration, we examine how this molecule bridges cardiac and oncology research, all while maintaining rigorous scientific credibility and practical utility.

• Structure-Based Screening Identifies NSP15 Inhibitors for SA

  2026-05-12

  This study employed structure-based virtual screening of natural products to identify potent inhibitors of the SARS-CoV-2 NSP15 endoribonuclease, revealing thymopentin and oleuropein as promising leads. The findings illuminate new avenues for antiviral research and underscore the importance of targeting NSP15 in viral immune evasion.

• Sodium Ascorbate: Mechanism, Evidence, and Cancer Research U

  2026-05-11

  Sodium Ascorbate, a mineral salt of ascorbic acid, demonstrates robust induction of intracellular ROS and necrotic tumor cell death in preclinical cancer models. Its unique solubility and bioavailability profile make it a preferred tool in glioblastoma multiforme research. This article provides a fact-based, structured overview with verifiable citations.

• Metformin HCl Inhibits Tendon Ossification via Nr4a1/Wnt/β-c

  2026-05-11

  This study demonstrates that Metformin Hydrochloride (Metformin HCl) markedly reduces heterotopic ossification in mouse Achilles tendon models by downregulating the Nr4a1/Wnt/β-catenin signaling pathway. The findings reveal a novel molecular target for non-surgical intervention in pathological soft tissue ossification, with direct implications for metabolic and bone disorder research.

• Repurposing Novobiocin: In Vitro Activity Against SFTSV

  2026-05-10

  A recent study systematically screened FDA-approved drugs for antiviral activity against severe fever with thrombocytopenia syndrome virus (SFTSV). Novobiocin emerged as a promising aminocoumarin antibiotic with significant in vitro efficacy and minimal cytotoxicity, supporting its potential in antiviral compound screening and drug repurposing research.

• (S)-(+)-Dimethindene maleate for Selective M2 Receptor Antag

  2026-05-09

  (S)-(+)-Dimethindene maleate enables precise antagonism of the muscarinic M2 and histamine H1 receptors, supporting targeted studies in autonomic regulation and cardiovascular physiology. It is not intended for diagnostic, therapeutic, or clinical applications and should be reserved for controlled research use only.

• HPF: Enabling Precision hROS Detection for Translational Onc

  2026-05-08

  This thought-leadership article unpacks the pivotal role of HPF (hydroxyphenyl fluorescein) in advancing highly reactive oxygen species (hROS) detection within translational cancer research. By integrating mechanistic insights, practical protocols, and strategic guidance, it positions HPF not merely as a technical solution, but as a catalyst for innovation in multimodal phototherapy and oxidative stress biology.

• Cyclo (-RGDfC) in High-Throughput Tumor Targeting: Stability

  2026-05-08

  Explore how Cyclo (-RGDfC) advances tumor targeting and angiogenesis research through unmatched integrin αvβ3 specificity and robust stability. This article uniquely connects peptide design with high-throughput assay innovation, offering practical guidance for next-generation cancer research.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Protoco

  2026-05-07

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive, specific detection of rabbit primary antibodies in fluorescence-based assays, solving common challenges in signal amplification and background minimization. It is best used in immunofluorescence, immunocytochemistry, and flow cytometry where robust and reproducible detection of rabbit IgG is required. This reagent is not suitable for protocols targeting non-rabbit primaries or applications incompatible with sodium azide.

8446 records 16/564 page Previous Next First page 上5页 1617181920 下5页 Last page